Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy

  • El Awady M
  • Anany M
  • Esmat G
 et al. 
  • 28


    Mendeley users who have this article in their library.
  • 20


    Citations of this article.


Response to interferon therapy and disease progression in hepatitis C virus (HCV) infected patients differs among individuals, suggesting a possibility of a contribution of host genetic factors. 2'-5'-oligoadenylate synthetase 1 (OAS1), an important component of the innate immune system with a proven antiviral function, may therefore have a relationship with the response to interferon therapy and clinical course of HCV disease. Our aim was to determine the frequency of single nucleotide polymorphism (SNP) at exon 7 splice acceptor site (SAS) of the OAS1 gene in relation to the interferon response and status of HCV infection.

Author-supplied keywords

  • Hepatitis C virus
  • Liver fibrosis
  • OAS1
  • Response to interferon therapy
  • Single nucleotide polymorphism

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Mostafa K. El Awady

  • Mohamed A. Anany

  • Gamal Esmat

  • Naglaa Zayed

  • Ashraf A. Tabll

  • Amr Helmy

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free